Latest Breaking News On - Company current report on form - Page 2 : comparemela.com

Vivakor Provides Update on Empire s Hydrogen Project at the Port of West Virginia

Vivakor Provides Update on Empire s Hydrogen Project at the Port of West Virginia
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesWest virginiaChris beaufaitBernard brownEmpire diversified energyWhite claw colorado cityCompany current report on formHeartland water technologyVivakor investor relations departmentEmpire diversified energy incIts silver fuels delhiVivakor incRemediation processing centersExchange commissionEmpire green generationAppalachian regional clean hydrogen hub

Primis Financial Corp Announces Notification of Delinquency with Nasdaq

/PRNewswire/ On May 16, 2024, Primis Financial Corp. (NASDAQ: FRST) ("Primis" or the "Company") received an expected delinquency notification letter (the.

United statesDennisj zember jrMatthewa switzerPrimis financial corpSecurities exchangeCompany current report on formExchange commissionCompany quarterly reports on formNasdaq listing qualifications departmentPrimis bankCompany annual report on formPrimis financialListing qualifications departmentNasdaq listing ruleQuarterly reportAnnual report

Lineage Cell Therapeutics : Opinion of Sheppard Mullin Richter & Hampton, LLP relating to the legality of the ATM Shares

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT .

State of californiaUnited statesSan diegoSheppard mullin richter hamptonGeorgea samuelCompany current report on formRegistration statement the base prospectusSecurities exchangeCompany registration statement on formB riley securities incCommon shares the companyExchange commissionLineage cell therapeutics incCommission file numberExchange commission theRichter hampton

MyMD Pharmaceuticals Secures Strategic Investments

Up to $42 Million in Two-Part Funding from New Strategic Investor and Existing Shareholders with Committed Closing of an Aggregate of $14 Million Up Front .

Chris chapmanMymd pharmaceuticals incPharmacyte biotech incCompany annual report on formExchange commissionCompany current report on formPharmacyte biotechChief medical officerSeriesg preferred stockCurrent reportSecurities actNasdaq stock marketAnnual report

MyMD Pharmaceuticals : Secures Strategic Investments - Form 8-K

MyMD Pharmaceuticals Secures Strategic Investments Up to $42 Million in Two-Part Funding from New Strategic Investor and Existing Shareholders with Committed Closing of an.

Chris chapmanRobert schatzPharmacyte biotech incMymd pharmaceuticals incCompany current report on formExchange commissionCompany annual report on formMymd pharmaceuticals secures strategic investmentsTwo part fundingNew strategic investorExisting shareholdersCommitted closingPharmacyte biotechChief medical officerSeriesg preferred stockCurrent report